Literature DB >> 30139830

Genomic precision medicine: on the TRK.

Sarah Elitzur1, Shai Izraeli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30139830     DOI： 10.1182/blood-2018-06-857540

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  1 in total

1.  Larotrectinib in TRK fusion-positive pediatric B-cell acute lymphoblastic leukemia.

Authors:  Denis M Schewe; Lennart Lenk; Fotini Vogiatzi; Dorothee Winterberg; Annika V Rademacher; Swantje Buchmann; Dahlia Henry; Anke K Bergmann; Gunnar Cario; Michael C Cox
Journal:  Blood Adv       Date:  2019-11-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.